Published May 25, 2024 | Version v1
Journal article Open

ETIOLOGICAL FACTORS AND DIAGNOSTIC CRITERIA OF SEPSIS IN THE INTENSIVE CARE UNIT (ICU)

Authors/Creators

Description

The aim of our study was to identify etiological factors and resistant strains among them to prevent death from severe sepsis and septic shock in the modern era. Hemoculture was obtained from blood samples using a BACT/ALERT® 3D analyzer. Antibiotic resistance of bacteria was studied using the Kirby-Bauer disk diffusion 
method according to the instructions of the Clinical and Laboratory Standards Institute (CLSI) 77 (55.8±4.2) Gram (-), 61 (44.2±6.2) Gram (+ ) bacteria were present. In our study, the synthesis of ESBL in RISK Klebsiella spp. In most cases, 15 (71%) and Escherichia coli 15 (75%) strains were identified. 58% were found in S.aureus (MRSA) 
strains.

Files

Annali d’Italia №55 2024-22-28.pdf

Files (686.8 kB)

Name Size Download all
md5:b7cb90fabad23ea16bf28ab3f48a8e35
686.8 kB Preview Download

Additional details

References

  • 1. Esra N.Ü., Feride K. Sepsis Patogenezi, Tanı ve Tedavisi Sepsiste Oksidatif Stres ve Sepsis İnflamasyon İlişkisi, Sepsiste Deneysel Modeller 1 Erciyes Üniversitesi, Veteriner Fakültesi Dergisi Kayseri-TÜRKİYE ORCID: a 0000-0002-5682-2789; b 0000-0002-3963-5199 19(2), 145-151, 2022 DOI: 10.32707/ercivet.1142245 2. Seymour C.W., Gesten F., Prescott H.C., et al. Time to Treatment and Mortality during Mandated Emergency Care for Sepsis. N Engl J Med. 2017; 376(23): 2235–44. DOI: 10.1056/NEJMoa1703058 3. Zilberberg M.D., Nathanson B.H., Sulham K., et al. Carbapenem resistance, inappropriate empiric treatment and outcomes among patients hospitalized with Enterobacteriaceae urinary tract infection, pneumonia and sepsis. BMC Infect Dis. 2017; 17(1): 279. DOI: 10.1186/s12879-017-2383-z 4. А. Bykov, M. Suvorova, I. Sychev, I., et al. Infections in the intensive care unit caused by carbapenemase-producing Klebsiella pneumoniae and Acinetobacter baumannii: clinical and microbiological characteristics and outcome [abstract]. 29th European Conference on Clinical Microbiology and Infectious Diseases. Amsterdam, The Netherlands, April 13–16, 2019. 5. Kim H., Kim E.S., Lee S.C., et al. Decreased Incidence of Methicillin-Resistant Staphylococcus aureus Bacteremia in Intensive Care Units: a 10-Year Clinical, Microbiological, and Genotypic Analysis in a Tertiary Hospital. Antimicrob Agents Chemother. 2020; 64(10): e01082–20. DOI: 10.1128/AAC.01082- 20 6. Kohler P.P., Volling C., Green K., et al. Carbapenem Resistance, Initial Antibiotic Therapy, and Mortality in Klebsiella pneumoniae Bacteremia: A Systematic Review and Meta-Analysis. Infect Control Hosp Epidemiol. 2017; 38(11): 1319–28. DOI: 10.1017/ice.2017.197 7. Lai C.C., Shi Z.Y., Chen Y.H., et al. Effects of various antimicrobial stewardship programs on antimicrobial usage and resistance among common gram-negative bacilli causing health care-associated infections: A multicenter comparison. J Microbiol Immunol Infect. 2016; 49(1): 74–82. DOI: 10.1016/j.jmii.2015.05.011 8. Chen Y., Chen Y., Liu P., et al. Risk factors and mortality for elderly patients with bloodstream infection of carbapenem resistance Klebsiella pneumoniae: a 10-year longitudinal study. BMC Geriatr. 2022; 22(1): 573. DOI: 10.1186/s12877-022- 03275-1 9. Pogue J.M., Kaye K.S., Cohen D.A., et al. Appropriate antimicrobial therapy in the era of multidrug-resistant human pathogens. Clin Microbiol Infect. 2015; 21(4): 302–12. DOI: 10.1016/j.cmi.2014.12.025 10. Perez K.K., Olsen R.J., Musick W.L., et al. Integrating rapid diagnostics and antimicrobial stewardship improves outcomes in patients with antibiotic-resistant Gram-negative bacteremia. J Infect. 2014; 69(3): 216–25. DOI: 10.1016/j.jinf.2014.05.005 11. Zhuravleva M.V., Rodionov B.A., Lysenko M.A., et al. Study of Cases of Bacteremia with GramNegative Pathogens with Multiple and Extreme Antibiotic Resistance in Real Clinical Practice. Antibiotics and Chemotherapy. 2021; 66(3–4): 27–34. 12. Jouffroy R, Saade A, Carpentier A, et al. Triage of septic patients using qSOFA criteria at the SAMU regulation: a retrospective analysis. Prehosp Emerg Care. 2018;22(1):84-90. (Retrospective; 141 patients) 13. Raith EP, Udy AA, Bailey M, et al. Prognostic accuracy of the SOFA score, SIRS criteria, and qSOFA score for in-hospital mortality among adults with suspected infection admitted to the intensive care unit. JAMA. 2017;317(3):290-300. (Retrospective; 184,875 patients)Vora N.M., Kubin C.J., Furuya E.Y. Appropriateness of gram-negative agent use at a tertiary care hospital in the setting of significant antimicrobial resistance. Open Forum Infect Dis. 2015; 2(1):ofv009. DOI: 10.1093/ofid/ofv009 14. Haydar S, Spanier M, Weems P, et al. Comparison of qSOFA score and SIRS criteria as screening mechanisms for emergency department sepsis. Am J Emerg Med. 2017;35(11):1730-1733. (Retrospective; 199 patients) 15. Tan M, Lu Y, Jiang H, Zhang L (2019) The diagnostic accuracy of procalcitonin and C-reactive protein for sepsis: a systematic review and metaanalysis. J Cell Biochem 120(4):5852–5859 16. Eucast.org [Internet]. The European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters. Version 10.0, 2020. Available from: https://www.eucast.org 17. Eucast.org [Internet]. Antimicrobial susceptibility tests on groups of organisms or agents for which there are no EUCAST breakpoints [updated 1 December 2021]. Available from: https://www.eucast.org 18. Stojewska M, Wasek-Buko M, Jakub B, Wisniewska-Ulfig D, Goleniowska-Krol A, Szymanska A, et al. Evaluation of serum chemokine RANTES concentration as a biomarker in the diagnosis of early-onset severe infections in neonates. Postepy Hig Med Dosw (Online). 2016;70:272–9. 19. Parajuli N.P., Maharjan P., Parajuli H., Joshi G., Paudel D., Sayami S., Khanal P.R. High rates of multidrug resistance among uropathogenic Escherichia coli in children and analyses of ESBL producers from Nepal. Antimicrob. Resist. Infect. Control. 2017;6(1):9.
  • 20. Somily A.M., Habib H.A., Absar M.M., Arshad M.Z., Manneh K., Al Subaie S.S., Al Hedaithy M.A., Sayyed S.B., Shakoor Z., Murray T.S. ESBLproducing Escherichia coli and Klebsiella pneumoniae at a tertiary care hospital in Saudi Arabia. J. Infect. Dev. Ctries. 2014;8(9):1129–1136. doi: 10.3855/jidc.4292. 21. Suvorova M., Sychev I., Bykov A., et al. Analysis of Gram-negative bacteraemia and sensitivity of blood isolates in the ICU department of Moscow (Russia) emergency hospital from 2003 to 2018 [abstract]. 29th European Conference on Clinical Microbiology and Infectious Diseases. Amsterdam, The Netherlands, April 13–16, 2019. 22. Cienfuegos-Gallet A.V., Ocampo de Los Ríos A.M., Sierra Viana P., et al. Risk factors and survival of patients infected with carbapenem-resistant Klebsiella pneumoniae in a KPC endemic setting: a case-control and cohort study. BMC Infect Dis. 2019; 19(1): 830. 23. Matos E.C.O.d., Andriolo R.B., Rodrigues Y.C., Lima P.D.L.d., Carneiro I.C.d.R.S., Lima K.V.B. Mortality in patients with multidrug-resistant Pseudomonas aeruginosa infections: A meta-analysis. Rev. Soc. Bras. Med. Trop. 2018;51:415–420. doi: 10.1590/0037-8682-0506-2017. 24. Bassetti M, Vena A, Croxatto A, Righi E, Guery B. How to manage Pseudomonas aeruginosa infections. Drugs in Context. 2018;7:212527. 25. De Oliveira D.M., Forde B.M., Kidd T.J., Harris P.N., Schembri M.A., Beatson S.A., Paterson D.L., Walker M.J. Antimicrobial resistance in ESKAPE pathogens. Clin. Microbiol. Rev. 2020;33:e00181-19. doi: 10.1128/CMR.00181-19. 26. El-Sokkary R., Uysal S., Erdem H., et al. Profiles of multidrug-resistant organisms among patients with bacteremia in intensive care units: an international ID-IRI survey. Eur J Clin Microbiol Infect Dis. 2021; 40(11): 2323–34. DOI: 10.1007/s10096- 021-04288-1 27. Timsit J.F., Ruppé E., Barbier F., et al. Bloodstream infections in critically ill patients: an expert statement. Intensive Care Med. 2020; 46(2): 266–84. DOI: 10.1007/s00134-020-05950-6